Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Summary

Phase II trial to study the effectiveness of gefitinib in treating patients who have stage IIIB or stage IV non-small cell lung cancer. Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of non-small cell lung cancer

Timeline

Start

2001-12

Primary completion

2004-12

Completion

—

Drugs

Indications